Synergistic Photoantimicrobial Chemotherapy of Methylene Blue-Encapsulated Chitosan on Biofilm-Contaminated Titanium
Overview
Affiliations
Intensive efforts have been made to eliminate or substantial reduce bacterial adhesion and biofilm formation on titanium implants. However, in the management of peri-implantitis, the methylene blue (MB) photosensitizer commonly used in photoantimicrobial chemotherapy (PACT) is limited to a low retention on the implant surface. The purpose of this study was to assess enhancive effect of water-soluble quaternary ammonium chitosan (QTS) on MB retention on biofilm-infected SLA (sandblasted, large grid, and acid-etched) Ti alloy surfaces in vitro. The effectiveness of QTS + MB with different concentrations in eliminating Gram-negative or Gram-positive bacteria was compared before and after PACT. Bacterial counting and lipopolysaccharide (LPS) detection were examined, and then the growth of human osteoblast-like MG63 cells was evaluated. The results indicated that the synergistic QTS + MB with retention ability significantly decreased the biofilm accumulation on the Ti alloy surface, which was better than the same concentration of 1 wt% methyl cellulose (MC). More importantly, the osteogenic activity of MG63 cells on the disinfected sample treated by QTS + MB-PACT modality was comparable to that of sterile Ti control, significantly higher than that by MC + MB-PACT modality. It is concluded that, in terms of improved retention efficacy, effective bacteria eradication, and enhanced cell growth, synergistically, PACT using the 100 μg/mL MB-encapsulated 1% QTS was a promising modality for the treatment of peri-implantitis.
In vitro cytotoxicity and antibacterial activity of hypochlorous acid antimicrobial agent.
Tsai C, Chung J, Ding S, Chen C J Dent Sci. 2024; 19(1):345-356.
PMID: 38303880 PMC: 10829635. DOI: 10.1016/j.jds.2023.07.007.
Antimicrobial photodynamic therapy for the treatment of oral infections: A systematic review.
Jao Y, Ding S, Chen C J Dent Sci. 2023; 18(4):1453-1466.
PMID: 37799910 PMC: 10548011. DOI: 10.1016/j.jds.2023.07.002.
Chen C, Wang J, Huang Y, Yu Y, Wu T, Ding S Pharmaceutics. 2023; 15(4).
PMID: 37111576 PMC: 10146948. DOI: 10.3390/pharmaceutics15041090.
Photodynamic Therapy for Peri-Implant Diseases.
Rahman B, Acharya A, Siddiqui R, Verron E, Badran Z Antibiotics (Basel). 2022; 11(7).
PMID: 35884171 PMC: 9311944. DOI: 10.3390/antibiotics11070918.